Anaerobic cocci and their role in infection processes

"Los Cocos Anaerobios y su Papel en los procesos Infecciosos "

This review article addresses the significant role of anaerobic cocci in the etiology of various human infections, highlighting their presence both in the normal microbiota and under pathological conditions. These microorganisms, ubiquitous on skin and mucosal surfaces, can become opportunistic pathogens under specific circumstances, contributing to a broad spectrum of infections from superficial abscesses to more severe complications such as endocarditis and meningitis. Among the most relevant genera are Finegoldia and Parvimonas, known for their ability to trigger inflammatory responses and interact with host tissues, thereby facilitating the infectious process. The accurate identification and classification of these anaerobic cocci represent a challenge due to their genetic and phenotypic diversity, underscoring the importance of advancing our knowledge of their biology through genomic techniques. This work emphasizes the need for further study of anaerobic cocci to better understand their contribution to human infections and to develop more effective therapeutic strategies.

REFERENCIAS
1. Jawetz, Melnick & Adelberg. Microbiología Médica. Capítulo 9: patogenia de la infección bacteriana. 27a Edición. Editorial Mac Graw Hill. México 2016.
2. Cohen, J. The Evolution of Koch’s Postulates. Infectious Diseases. 2017: 1-3.
3. Grimes, Jay. "Postulados de Koch - entonces y ahora" . Sociedad Americana de Microbiología. 2006; 1:226.
4. Todd, Olivia; Peters, Brian. "Candida Albicans y Staphylococcus aureus patogenicidad e interacciones polimicrobianas: lecciones más allá de los postulados de Koch" . Diario de hongos. 2019; 5 (81): 81.
5. Heintz-Buschart, A., & Wilmes, P. (2018). Human gut microbiome: function matters. Trends in microbiology. 2018;26(7): 563-574.
6. Abrutyn E, Goldmann D, Scheckler W, eds. Saunders. infection control reference service (2nd ed). Philadelphia, Saunders, 2001.
7. Belinda S. Thompson, Erin L. Goodrich. Miscellaneous Infectious Diseases. Rebhun's Diseases of Dairy Cattle (Third Edition). 2018:737-783
8. Joanne Willey and Linda Sherwood and Christopher J. Woolverton. Prescott’s Microbiology.
11 th 2019. McGraw-Hill Education.
9. D. Zambrano. The role of anaerobic bacteria in human infections. Clin Ther. 1993;15(2):244-60; discussion 215.
10. Itzhak Brook. Spectrum and treatment of anaerobic infections. J Infect Chemother. 2016;22(1):1-13.
11. Jose Elıas Garcıa Sanchez, Marıa Jose Fresnadillo y Enrique Garcıa Sanchez Nuevas bacterias anaerobias implicadas en enfermedades infecciosas humanas. Facultad de Medicina, Universidad de Salamanca, España. Enferme Infecc Microbiol Clin. 2010; 28(3):173–184
12. Patrick R Murray. Microbiología Médica Básica. Student Consult. 1a 2018. Elsevier.
13. Struthers, Keith. Microbiología Clínica. 1a 2018 Manual Moderno.
14. Silvia C. Predari, María Adelaida Rossetti, Hebe M.Bianchini, Mirta R., Litterio Burki, María R. Rollet, María C. Legaria, Graciela Carloni, Ana DiMartino, Liliana Fernández, Laura Glioska,. Microorganismos anaerobios. Parte III. Investigaciones Médicas Alfredo Lanari, Universidad de Buenos Aires. Ciudad Autónoma de Buenos Aires, Argentina. Disponible en https://es.scribd.com/document/413119461/Parte-III.
15. Ariane Neumann , Lars Björck, Inga-Maria Frick. Finegoldia magna, an Anaerobic Gram-Positive Bacterium of the Normal Human Microbiota, Induces Inflammation by Activating Neutrophils. Front Microbiol. 2020. 29;11:65.
16. Holger Brüggemann, Anders Jensen, Seven Nazipi, Hüsnü Aslan, Rikke Louise Meyer, Anja Poehlein, Elzbieta Brzuszkiewicz, Munir A Al-Zeer, Volker Brinkmann, Bo Söderquist. Pan-genome analysis of the genus Finegoldia identifies two distinct clades, strain-specific heterogeneity, and putative virulence factors. Sci Rep . 2018 10;8(1):266.
17. Christofer Karlsson, Mette Eliasson, Anders I Olin, Matthias Mörgelin, Anna Karlsson, Martin Malmsten, Arne Egesten, Inga-Maria Frick. SufA of the opportunistic pathogen finegoldia magna modulates actions of the antibacterial chemokine MIG/CXCL9, promoting bacterial survival during epithelial inflammation. J Biol Chem . 2009. 23;284(43):29499-508.
18. Ozo Todo, Takatsugu Goto, Kazuaki Miyamoto, Shigeru Akimoto. Physical and genetic map of the Finegoldia magna (formerly Peptostreptococcus magnus) ATCC 29328 genome. FEMS Microbiology Letters. 2002; 210(1): 33-37
19. Boyanova L, Markovska R, Mitov I. Virulence arsenal of the most pathogenic species among the Gram-positive anaerobic cocci, Finegoldia magna. Anaerobe. 2016; 42:145-151.
20. Cobo F, Rodríguez-Granger J, Sampedro A, Navarro-Marí JM. Breast abscess due to Finegoldia magna in a non-puerperal women. Anaerobe. 2017; 47:183-184.
21. Alsubaie S, Dolgum S, Binkhamis K, Alweijri I, Bugshan A, Alzamil F. Finegoldia magna causing intramedullary thoracic spinal cord abscess in an infant. Anaerobe. 2019; 56:57-60.
22. Fernando Cobo, Javier Rodríguez-Granger, Antonio Sampedro, José María Navarro-Marí. Breast abscess due to Finegoldia magna in a non-puerperal women. Anaerobe. 2017; 47:183-184.
23. Bonnet É, Galinier JL, Fontenel B, Dongay B, Soula P. Endocardite à Finegoldia magna [Finegoldia magna endocarditis]. Med Mal Infect. 2017; 47(1):65-67.
24. Söderquist B, Björklund S, Hellmark B, Jensen A, Brüggemann H. Finegoldia magna Isolated from Orthopedic Joint Implant-Associated Infections. J Clin Microbiol. 2017; 55(11):3283-3291.
25. García-Hita M, Sigona-Giangreco IA, Rincón-Almanza A, Frasquet-Artes J. Parvimonas micra infective endocarditis. Enferm Infecc Microbiol Clin (Engl Ed). 2020; 38(9):449-450
26. Cao H, Cheng Y, Li M. Periprosthetic joint infection caused by Parvimonas micra. Enferm Infecc Microbiol Clin. 2021; 39(3):162-163.
27. Watanabe T, Hara Y, Yoshimi Y, Fujita Y, Yokoe M, Noguchi Y. Clinical characteristics of bloodstream infection by Parvimonas micra: retrospective case series and literature review. BMC Infect Dis. 2020; 5; 20(1):578.
28. Baghban A, Gupta S. Parvimonas micra: A rare cause of native joint septic arthritis. Anaerobe. 2016; 39:26-7.
29. Marta Garrido-Jareño, Juan Frasquet-Artes, María Tasias-Pitarch. José Luis López-Hontangas. Primer caso de absceso renal por Parvimonas micra. Enfermedades Infecciosas y Microbiología Clínica. 2019; 37(2): 140-141.
30. Ko JH, Baek JY, Kang CI, Lee WJ, Lee JY, Cho SY, Ha YE, Kim SH, Chung DR, Peck KR, Lee NY, Song JH. Bacteremic meningitis caused by Parvimonas micra in an immunocompetent host. Anaerobe. 2015; 34:161-163.
31. Shtaya A, Schuster H, Riley P, Harris K, Hettige S. Oesophageal pleural fistula presenting with Parvimonas micra infection causing cervical and brain abscesses. Anaerobe. 2017; 47:233-237.
32. Cobo F, Rodríguez-Granger J, Sampedro A, Aliaga-Martínez L, Navarro-Marí JM. Pleural effusion due to Parvimonas micra. A case report and a literature review of 30 cases. Rev Esp Quimioter. 2017; 30(4):285-292.
33. Bassa Malondra A., García Gasalla M., Cladera A., Gaeau M. Endocarditis por Peptostreptococcus: presentación de dos casos y revisión de la literatura. An. Med. Interna. 2008; 25 (5): 226-228.
34. Minces LR, Shields RK, Sheridan K, Ho KS, Silveira FP. Peptostreptococcus infective endocarditis and bacteremia. Analysis of cases at a tertiary medical center and review of the literature. Anaerobe. 2010;16(4):327-30.
35. Cone LA, Battista BA, Shaeffer CW Jr. Endocarditis due to Peptostreptococcus anaerobius: case report and literature review of peptostreptococcal endocarditis. J Heart Valve Dis. 2003; 12(3):411-3.
36. Ho Tsoi Eagle S. H. Chu Xiang Zhang Jianqiu Sheng Geicho Nakatsu Siew C. Ng Anthony W. H. Chan Francis K. L. Chan Joseph J. Y. Sung Jun Yu. Peptostreptococcus anaerobius Induces Intracellular Cholesterol Biosynthesis in Colon Cells to Induce Proliferation and Causes Dysplasia in Mice. Gastroenterology. 2017; 152(6):1419-1433
37. Xiaohang Long, Tong Li, Jun Yu. Functional Investigation of a Novel Oncogenic Bacterium Peptostreptococcus anaerobius in Colorectal Carcinogenesis. Gastroenterology. 2018; 154(6),1:40 – 41
38. Costa C, Santiago M, Ferreira J, Rodrigues M, Carvalho P, Silva J, Malcata A. Septic arthritis caused by Peptostreptococcus asaccharolyticus. Acta Reumatol Port. 2016; 41(3):271-272.
39. Downes J, Wade WG. Peptostreptococcus stomatis sp. nov., isolated from the human oral cavity. Int J Syst Evol Microbiol. 2006;56(Pt 4):751-754.
40. Yu J, Feng Q, Wong SH, Zhang D, Liang QY, Qin Y, Tang L, Zhao H, Stenvang J, Li Y, Wang X, Xu X, Chen N, Wu WK, Al-Aama J, Nielsen HJ, Kiilerich P, Jensen BA, Yau TO, Lan Z, Jia H, Li J, Xiao L, Lam TY, Ng SC, Cheng AS, Wong VW, Chan FK, Xu X, Yang H, Madsen L, Datz C, Tilg H, Wang J, Brünner N, Kristiansen K, Arumugam M, Sung JJ, Wang J. Metagenomic analysis of faecal microbiome as a tool towards targeted non-invasive biomarkers for colorectal cancer. Gut. 2017;66(1):70-78.
41. Osman MA, Neoh HM, Ab Mutalib NS, Chin SF, Mazlan L, Raja Ali RA, Zakaria AD, Ngiu CS, Ang MY, Jamal R. Parvimonas micra, Peptostreptococcus stomatis, Fusobacterium nucleatum and Akkermansia muciniphila as a four-bacteria biomarker panel of colorectal cancer. Sci Rep. 2021. 3;11(1):2925.
42. Ryu SW, Kim JS, Oh BS, Yu SY, Lee JS, Park SH, Kang SW, Lee J, Lee MK, Rhee MS, Jung H, Hur TY, Kim HB, Kim JK, Lee JH, Lee JH. Peptoniphilus faecalis sp. nov., isolated from swine faeces. Int J Syst Evol Microbiol. 2021;71(6).
43. Diop K, Diop A, Michelle C, Richez M, Rathored J, Bretelle F, Fournier PE, Fenollar F.
Description of three new Peptoniphilus species cultured in the vaginal fluid of a woman diagnosed with bacterial vaginosis: Peptoniphilus pacaensis sp. nov., Peptoniphilus raoultii sp. nov., and Peptoniphilus vaginalis sp. nov. Microbiologyopen. 2019;8(3):e00661
44. Song Y, Liu C, Finegold SM. Peptoniphilus gorbachii sp. nov., Peptoniphilus olsenii sp. nov., and Anaerococcus murdochii sp. nov. isolated from clinical specimens of human origin. J Clin Microbiol. 2007 Jun;45(6):1746-52.
45. Müller-Schulte E, Heimann KC, Treder W. Peptoniphilus asaccharolyticus - Commensal, pathogen or synergist? Two case reports on invasive Peptoniphilus asaccharolyticus infection. Anaerobe. 2019; 59:159-162.
46. Verma R, Morrad S, Wirtz JJ. Peptoniphilus asaccharolyticus-associated septic arthritis and osteomyelitis in a woman with osteoarthritis and diabetes mellitus. BMJ Case Rep. 2017; (2): bcr2017219969.
47. Cobo F, Rodríguez-Granger J, Sampedro A, Navarro-Marí JM. Peritoneal infection due to Peptoniphilus harei in a patient with intestinal occlusion. Anaerobe. 2017; 44:126-127.
48. Citron DM, Tyrrell KL, Goldstein EJ. Peptoniphilus coxii sp. nov. and Peptoniphilus tyrrelliae sp. nov. isolated from human clinical infections. Anaerobe. 2012;18(2):244-8.
49. Cobo F, Navarro-Marí JM. First description of Anaerococcus octavius as cause of bacteremia. Anaerobe. 2020;61:102130.
50. Morand A, Cornu F, Tsimaratos M, Lagier JC, Cadoret F, Fournier PE, Raoult D. Anaerococcus urinomassiliensis sp. nov., isolated from a urine sample of a 17-year-old boy affected by autoimmune hepatitis and membranoproliferative glomerulonephritis. New Microbes New Infect. 2016. 6;13:56-8.
51. Veloo ACM, de Vries ED, Jean-Pierre H, van Winkelhoff AJ. Anaerococcus nagyae sp. nov., isolated from human clinical specimens.. Anaerobe. 2016;38:111-115
52. Tall ML, Pham TPT, Bellali S, Ngom II, Delerce J, Lo CI, Raoult D, Fournier PE, Levasseur A. Anaerococcus marasmi sp. nov., a new bacterium isolated from human gut microbiota.
New Microbes New Infect. 2020.15;35:100655.
53. Dione N, Bellali S, Yasir M, Azhar EI, Bibi F, Beye M, Armstrong N, Cadoret F, Jiman-Fatani AA, Helmy N, Rathored J, Labas N, Fournier PE, Raoult D, Lagier JC. Anaerococcus jeddahensis sp. nov., a New Bacterial Species Isolated From Healthy Nomadic Bedouin Woman From Saudi Arabia. Curr Microbiol. 2018;75(11):1419-1428.
54. Labutti K, Pukall R, Steenblock K, Glavina Del Rio T, Tice H, Copeland A, et al. (Septiembre de 2009). "Secuencia completa del genoma de la cepa tipo Anaerococcus prevotii (PC1)". Estándares en Ciencias Genómicas. 1(2): 159–65.
55. Labutti K, Pukall R, Steenblock K, Glavina Del Rio T, Tice H, Copeland A, Cheng JF, Lucas S, Chen F, Nolan M, Bruce D, Goodwin L, Pitluck S, Ivanova N, Mavromatis K, Ovchinnikova G, Pati A, Chen A, Palaniappan K, Land M, Hauser L, Chang YJ, Jeffries CD, Chain P, Saunders E, Brettin T, Detter JC, Han C, Göker M, Bristow J, Eisen JA, Markowitz V, Hugenholtz P, Kyrpides NC, Klenk HP, Lapidus A. Complete genome sequence of Anaerococcus prevotii type strain (PC1). Stand Genomic Sci. 2009 Sep 24;1(2):159-65
56. Falsen E, Collins MD, Welinder-Olsson C, Song Y, Finegold SM, Lawson PA. Fastidiosipila sanguinis gen. nov., sp. nov., a new Gram-positive, coccus-shaped organism from human blood. Int J Syst Evol Microbiol. 2005;55(Pt 2):853-858.
57. Beauruelle C, Le Bars H, Pougnet L, Lesecq L, Buisson P, Héry-Arnaud G. First human case of Fastidiosipila sanguinis infection. J Clin Microbiol. 2014;52(7):2713-5.
58. Ramanathan A, Gordon SM, Shrestha NK. A case series of patients with Gemella endocarditis. Diagn Microbiol Infect Dis. 2020;97(1):115009.
59. Ulger-Toprak N, Summanen PH, Liu C, Rowlinson MC, Finegold SM. Gemella asaccharolytica sp. nov., isolated from human clinical specimens. Int J Syst Evol Microbiol. 2010;60(Pt 5):1023-1026.
60. Romero-Velez G, Pereira X, Narula A, Kim PK. Gemella morbillorum as a source bacteria for necrotising fasciitis of the torso. BMJ Case Rep. 2020. 6;13(1):e231727.
61. Villamil C lago, Villar del C Alberto, Masa V Luis A. Absceso cutáneo por Gemella morbillorum. Rev. chil. infectol. 2009; 26( 5 ): 464-465
62. Fangous MS, Hémon F, Graf P, Samier-Guérin A, Alavi Z, Le Bars H, Le Berre R. Bone infections caused by Gemella haemolysans. Med Mal Infect. 2016;46(8):449-452.
63. Zaidi SJ, Husayni T, Collins MA. Gemella bergeri infective endocarditis: a case report and brief review of literature. Cardiol Young. 2018;28(5):762-764.
64. Maiko Otomo, Masato Saitoh, Riyoko Tamai, Yusuke Kiyoura, Izumi Mashima, Citra F Theodorea, Ariadna A Djais, Tadao Kunihiro, Yoshiaki Kawamura. Veillonella nakazawae sp. nov., an anaerobic Gram-negative coccus isolated from the oral cavity of Japanese children. Int J Syst Evol Microbiol. 2021; (1):71.
65. Struthers, Keith. Microbiología Clínica. 1a 2018. Manual Moderno.
66. PE Kolenbrander. RJ Palmer Jr. Paul Egland. Mutualism in in vitro Streptococcus - Veillonella spp. Oral Biofilms. Microscopy and Microanalysis 2009; 15.
67. Ratna Ramadhani, Ariadna Adisattya Djais, Boy Muchlis Bachtiar. Effect of Veillonella infantium on biofilm formation of oral Streptococcus. Int J App Pharm. 2019; 11, Special Issue 1.
68. Knapp, S., Brodal, C., Peterson, J., Qi, F., Kreth, J., and Merritt, J. Natural competence is common among clinical isolates of Veillonella parvula and is useful for genetic manipulation of this key member of the oral microbiome. Front. Cell. Infect. Microbiol. 2017. 7:139
69. Carlier, J. P. Veillonella. Bergey’s Manual Of Systematics Of Archaea And Bacteria. 2015. Hoboken, NJ: Wiley Online Library.
70. Simón Pedro Lubián-López, Fátima Galán-Sánchez, Manuel Rodriguez-Iglesias, Isabel Benavente-Fernández. Empiema intraventricular piogénico por Veillonella parvula en un recién nacido prematuro. Cartas científicas/Enferm Infecc Microbiol Clin. 2017; 35(8):539–542
71. R G Fisher and M R Denison. Veillonella parvula bacteremia without an underlying source. J Clin Microbiol. 1996; 34(12): 3235–3236.
72. D. Marriott, D. Stark, and J. Harkness. Veillonella parvula Discitis and Secondary Bacteremia: ¿a Rare Infection Complicating Endoscopy and Colonoscopy? J Clin Microbiol. 2007; 45(2): 672–674.
73. Maqsood A. Bhatti, Michael O. Frank. Veillonella parvula Meningitis: Case Report and Review of Veillonella Infections. Clinical Infectious Diseases. 2000; 31(3): 839–840
74. Maozhen Han, Gang Liu, Yajun Chen, Dong Wang and Yan Zhang. Comparative Genomics Uncovers the Genetic Diversity and Characters of Veillonella atypica and Provides Insights Into Its Potential Applications. Frontiers in Microbiology. 2020; 11, Article 1219: 1 – 12.
75. Crisafulli E, Bernardinello N, Alfieri V, Pellegrino F, Lazzari C, Gnetti L, Chetta A. A pulmonary infection by Actinomyces odontolyticus and Veillonella atypica in an immunocompetent patient with dental caries. Respirol Case Rep. 2019 Sep 30;7(9):e00493.
76. Han, M., Liu, G., Chen, Y., Wang, D., & Zhang, Y. Comparative Genomics Uncovers the Genetic Diversity and Characters of Veillonella atypica and Provides Insights Into Its Potential Applications. Frontiers in Microbiology. 2020; 11.
77. Zhou P, Xie G, Li X, Liu J, Qi F. Complete Genome Sequence of Veillonella atypica OK5, the First Transformable Strain in the Species.Genome Announc. 2017; 1:5(22)
78. Jonathan Scheiman, Jacob M Luber, Theodore A Chavkin, Tara MacDonald, Angela Tung, Loc-Duyen Pham, Marsha C Wibowo, Renee C Wurth, Sukanya Punthambaker, Braden T Tierney, Zhen Yang, Mohammad W Hattab, Julian Avila-Pacheco, Clary B Clish, Sarah Lessard, George M Church, Aleksandar D Kostic. Meta-omics analysis of elite athletes identifies a performance-enhancing microbe that functions via lactate metabolism. Nat Med. 2019;25(7):1104-1109.
79. Arif N, Do T, Byun R, Sheehy E, Clark D, Gilbert SC, Beighton D. Veillonella rogosae sp. nov., an anaerobic, Gram-negative coccus isolated from dental plaque. Int J Syst Evol Microbiol. 2008; 58(Pt 3):581-4.
80. Byum R, Carlier J-P, Jacques NA, Marchandin H, Hunter N. Veillonella denticariosi sp, nov., isolated from human carious dentine. Int J Syst Evol Microbiol. 2007; 57:2844-2848.
81. Estelle Jumas-Bilak, Jean-Philippe Carlier, Helene Jean-Pierre, Corinne Teyssier, Bernard Gay, Josiane campos. Veillonella montpellierensis sp.nov., a novel, anaerobic, Gram negative coccus isolated from human clinical samples. Int J of Syst Evol Microbiol 2008; 58: 581-584.
82. Tunney MM, Field TR, Moriarty TF, Patrick S, Doering G, Muhlebach MS, Wolfgang MC, Boucher R, Gilpin DF, McDowell A, Elborn JS. Detection of anaerobic bacteria in high numbers in sputum from patients with cystic fibrosis. Am J Respir Crit Care Med 2008; 177:995-1001
83. Murri M, Leiva I, Gomez-Zumaquero JM, Tinahones FJ, Cardona F, Soriguer F, Quepo-Ortuño MI. Gut microbiota in children with type I diabetes differs from that in healthy children: a case-control study. BMC Med 2013; 11:46
84. Al-Otaibi, F. E., and Al-Mohizea, M. M. Non-vertebral Veillonella species septicemia and osteomyelitis in a patient with diabetes: a case report and review of the literature. J. Case Rep. Med. 2014; 8:365.
85. Mashima I, Kamaguchi A, Miyakawa H, Nakazawa F. Veillonella tobetsuensis sp. nov., an anaerobic, gram-negative coccus isolated from human tongue biofilms. Int J Syst Evol Microbiol. 2013 ;63(4):1443-1449.
86. Takakura T, Anani H, Fadlane A, Fontanini A, Raoult D, Bou Khalil JY. Acidaminococcus provencensis sp. nov., a new bacterium isolated from a fresh human stool specimen. New Microbes New Infect. 2019; 14, 31:100573.
87. Peter C DeWeirdt, Kendall R Sanson, Annabel K Sangree, Mudra Hegde, Ruth E Hanna, Marissa N Feeley, Audrey L Griffith, Teng Teng, Samantha M Borys, Christine Strand, J Keith Joung, Benjamin P Kleinstiver, Xuewen Pan, Alan Huang, John G Doench. Optimization of AsCas12a for combinatorial genetic screens in human cells. Nat Biotechnol. 2021;39(1):94-104.
88. Yun-Juan Chang, Rüdiger Pukall, Elizabeth Saunders, Alla Lapidus, Alex Copeland, Matt Nolan, Tijana Glavina Del Rio, Susan Lucas, Feng Chen, Hope Tice, Jan-Fang Cheng, Cliff Han, John C. Detter, David Bruce, Lynne Goodwin, Sam Pitluck, Natalia Mikhailova, Konstantinos Liolios, Amrita Pati, Natalia Ivanova, Konstantinos Mavromatis, Amy Chen, Krishna Palaniappan, Miriam Land, Loren Hauser, Cynthia D. Jeffries, Thomas Brettin, Manfred Rohde, Markus Göker, James Bristow, Jonathan A. Eisen,Victor Markowitz, Philip Hugenholtz, Nikos C. Kyrpides, and Hans-Peter Klenk. Complete genome sequence of Acidaminococcus fermentans type strain (VR4T). Stand Genomic Sci. 2010; 30; 3(1): 1–14.
89. Struthers, Keith. Microbiología Clínica. 1a 2018.Manual Moderno.
90. Estelle Jumas-Bilak, Jean-Philippe Carlier, Hélène Jean-Pierre, Francine Mory, Corinne Teyssier, Bernard Gay, Josiane Campos, Hélène Marchandin. Acidaminococcus intestini sp. nov., isolated from human clinical samples. Int J Syst Evol Microbiol. 2007;57(10):2314-2319.
91. Mitsuo Sakamoto, Nao Ikeyama, Atsushi Toyoda, Takumi Murakami, Hiroshi Mori, Takao Lino, Moriya Ohkuma. Dialister hominis sp. nov., isolated from human faeces. Int J Syst Evol Microbiol. 2020; 70(1):589-595.
92. Downes J, Munson M, Wade WG. Dialister invisus sp. nov., isolated from the human oral cavity. Int J Syst Evol Microbiol. 2003 Nov;53(Pt 6):1937-40. doi: 10.1099/ijs.0.02640-0. PMID: 14657126.
93. Dialister micraerophilus sp. nov. and Dialister propionicifaciens sp. nov., isolated from human clinical samples. Int J Syst Evol Microbiol. 2005;55(6):2471-2478.
94. Jumas-Bilak E, Jean-Pierre H, Carlier JP, Teyssier C, Bernard K, Gay B, Campos J, Morio F, Marchandin H. Dialister micraerophilus sp. nov. and Dialister propionicifaciens sp. nov., isolated from human clinical samples. Int J Syst Evol Microbiol. 2005; 55(6):2471-2478.
95. Morotomi M, Nagai F, Sakon H, Tanaka R. Dialister succinatiphilus sp. nov. and Barnesiella intestinihominis sp. nov., isolated from human faeces. Int J Syst Evol Microbiol. 2008; 58(Pt 12):2716-20.
96. Marchandin H, Teyssier C, Campos J, Jean-Pierre H, Roger F, Gay B, Carlier JP, Jumas-Bilak E. Negativicoccus succinicivorans gen. nov., sp. nov., isolated from human clinical samples, emended description of the family Veillonellaceae and description of Negativicutes classis nov., Selenomonadales ord. nov. and Acidaminococcaceae fam. nov. in the bacterial phylum Firmicutes. Int J Syst Evol Microbiol. 2010 Jun;60(Pt 6):1271-1279. doi: 10.1099/ijs.0.013102-0. Epub 2009 Aug 10. PMID: 19667386.
97. Togo AH, Diop A, Tall ML, Million M, Khelaifia S, Maraninchi M, Raoult D, Fournier PE, Dubourg G. Draft genome and description of Negativicoccus massiliensis strain Marseille-P2082, a new species isolated from the gut microbiota of an obese patient. Antonie Van Leeuwenhoek. 2020 Jul;113(7):997-1008. doi: 10.1007/s10482-020-01414-5. Epub 2020 Apr 17. PMID: 32303967.